![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 AUROBINDO (1)
02 AUROBINDO PHARMA ITALIA Srl (1)
03 BOEHRINGER INGELHEIM (3)
04 BOEHRINGER INGELHEIM INT.GMBH (5)
05 Boehringer Ingelheim (Schweiz) GmbH (3)
06 Boehringer Ingelheim International GmbH (4)
07 MYLAN PHARMS INC (1)
08 Mepha Pharma AG (1)
09 PRINSTON INC (1)
10 SANDOZ GMBH (1)
11 TECH ORGANIZED (1)
12 TEVA B.V. (1)
01 NEVIRAPINE (7)
02 Nevirapine (16)
01 Italy (8)
02 Norway (4)
03 Switzerland (4)
04 USA (7)
01 Antic-calc Tablet (2)
02 Depottablett (1)
03 Melange (1)
04 Nevirapine 100Mg 90 Combined Oral Use Rp (1)
05 Nevirapine 200Mg 14 Joined' Oral Use (1)
06 Nevirapine 200Mg 60 Units Oral Use (4)
07 Nevirapine 400Mg 30 Joined' Oral Use Rp (1)
08 Nevirapine 50Mg/5Ml 240Ml Oral Use (1)
09 TABLET, EXTENDED RELEASE;ORAL (2)
10 TABLET;ORAL (5)
11 Tablet (4)